Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biotech
Sort By
Newest First
1 / 3
1 / 3
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
PAO-04-24-NI-01
April 02, 2024
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01
November 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01
October 05, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01
January 04, 2023
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-022-NI-01
December 23, 2022
Digital Therapeutics
Digital Therapeutics and the Song of the Future of Healthcare
Chris E. Rivera; Xavier A. Figueroa
EMulate Therapeutics
PAO-12-022-CL-02
December 20, 2022
Hemostatic
Stopping Bleeds and Saving Lives
Joe Landolina
Cresilon
PAO-11-022-CL-09
November 16, 2022
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01
September 06, 2022
Life Science Industrials
Life Science Industrials Are Key to the Growth of the Biopharma Industry
Reinhard Vogt
Dynamk Capital
PAO-07-022-CL-05
August 04, 2022
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03
July 12, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
June 24, 2022
Biotechs
10 More Biotechs Making Moves in 2022
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-07
June 24, 2022
CRO
Crafting a Successful Partnership with a Contract Research Organization
Aptinyx
PAO-06-022-CL-05
June 07, 2022
Enabling Drug Discovery Targeting Ion Channels
Doug Krafte, Ph.D.
Icagen
Ion Channels
May 19, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04
May 09, 2022
Investment
Bringing Value to Pharma and Biopharma
Commercial Healthcare Partners
PAO-04-22-R250-75
April 29, 2022
CRISPR Clinical Trial
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
SNIPR BIOME
PR-M04-22-11
April 20, 2022
Artificial Intelligence
Bringing Artificial Intelligence to Biopharma
TeselaGen Biotechnology
PAO-04-22-R250-07
April 01, 2022
Arizona Bioscience
Biotechnology Growth in Arizona
Arizona Bioindustry Association
PAO-04-22-R250-04
April 01, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
March 30, 2022
